ArticleFrontiers in public health2026
Medication literacy and its associated factors among middle-aged and older patients with comorbid coronary heart disease and type 2 diabetes mellitus: a cross-sectional study.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess medication literacy among middle-aged and older patients with comorbid coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM). Methods: A cross-sectional survey was conducted using convenience sampling. From October 2024 to May 2025, 260 hospitalized middle-aged and older patients with comorbid CHD and T2DM were recruited from a tertiary Grade A hospital in Chongqing, China. Data were collected using a general information questionnaire, the Medication Literacy Self-Assessment Scale for Patients with Comorbid Coronary Heart Disease and Diabetes, the Social Support Rating Scale, the Self-Efficacy for Appropriate Medication Use Scale, and the Patient Participation in Medication Decision-Making Scale. Descriptive statistics, univariate analysis, Pearson correlation analysis, and hierarchical linear regression analysis were performed. Results: A total of 254 valid questionnaires were included in the final analysis. The mean medication literacy score was 74.05 ± 12.23. Hierarchical linear regression analysis showed that participation in medication decision-making, social support level, educational level, self-efficacy for appropriate medication use, place of residence, and the ability to understand drug instructions were significantly associated factors of medication literacy (all Conclusion: Medication literacy among middle-aged and older patients with comorbid CHD and T2DM has room for further improvement. It was associated with factors across individual, social, cognitive and functional, and healthcare system levels. Individualized interventions and multilevel support systems should be developed to improve medication literacy and promote medication safety in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.